☆ 4.7 Editorial Material

Biomarkers of Antiangiogenic Therapy: How Do We Move From Candidate Biomarkers to Valid Biomarkers

JOURNAL OF CLINICAL ONCOLOGY (2010)

Journal

JOURNAL OF CLINICAL ONCOLOGY

Volume 28, Issue 2, Pages 183-185

Publisher

AMER SOC CLINICAL ONCOLOGY

DOI: 10.1200/JCO.2009.24.8021

Keywords

-

Categories

Oncology

Funding

NCI NIH HHS [P01 CA080124] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Endocrinology & Metabolism

How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic?

Michael J. Haller, Laura M. Jacobsen, Amanda L. Posgai, Desmond A. Schatz

Summary: Research-based immunotherapy trials for autoimmune diseases like type 1 diabetes have been suspended due to the COVID-19 pandemic, but studies show children and adolescents with diabetes may not have increased risk. It is important to carefully resume these trials and take measures to mitigate infection risks.

DIABETES (2021)

Add to Collection

Article Gastroenterology & Hepatology

How Do We Predict a Patient's Disease Course and Whether They Will Respond to Specific Treatments?

Bram Verstockt, Miles Parkes, James C. Lee

Summary: Gastroenterologists face challenging decisions when managing inflammatory bowel disease. The effectiveness of treatment and patient response can vary greatly, and the growing therapeutic options only complicate decision-making. However, other specialties have begun to use molecular heterogeneity to provide insights into predicting disease course and treatment response for patients with inflammatory bowel disease.

GASTROENTEROLOGY (2022)

Add to Collection

Editorial Material Oncology

In a search of a protective titer: Do we or do we not need to know?

Ancha Baranova, Vikas Chandhoke, Alena V. Makarova, Boris Veytsman

Summary: The level of postvaccine protection relies on antibodies and T-cell responses. Recent studies suggest that antibodies may serve as a good indicator of protection, especially for SARS-CoV-2. Quantitative antibody analysis remains crucial for assessing protection against the disease.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Add to Collection

Review Respiratory System

Interstitial lung abnormalities: What do we know and how do we manage?

Qi Liu, Hai Zhang, Baohui Han, Handong Jiang, Kian Fan Chung, Feng Li

Summary: This review article discusses the importance of recognizing interstitial lung abnormalities (ILAs) which can progress into interstitial lung disease (ILD) without intervention. Literature review on ILAs prevalence, etiology, symptoms, diagnostic biomarkers, clinical associations, and management was conducted from 2008 to 2020. Timely diagnosis, close monitoring, and appropriate intervention are essential for effectively managing ILAs, and further research is needed to improve management strategies.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2021)

Add to Collection

Article Forestry

Biological control of emerging forest diseases: How can we move from dreams to reality?

Simone Prospero, Leticia Botella, Alberto Santini, Cecile Robin

Summary: Biological control involves using living natural enemies to control other living organisms, and has gained importance due to increased environmental awareness. However, it is still underutilized in controlling fungal pathogens of forest trees. To enhance success rates, a holistic approach including top-down regulators and bottom-up forces should be adopted.

FOREST ECOLOGY AND MANAGEMENT (2021)

Add to Collection

Review Medical Informatics

Development and dissemination of infectious disease dynamic transmission models during the COVID-19 pandemic: what can we learn from other pathogens and how can we move forward?

Alexander D. Becker, Kyra H. Grantz, Sonia T. Hegde, Sophie Berube, Derek A. T. Cummings, Amy Wesolowski

Summary: The current COVID-19 pandemic has led to significant advancements in infectious disease dynamic transmission models being integrated into policy making and public health practice. These models offer systematic ways to investigate transmission dynamics, make short and long-term predictions, and evaluate intervention strategies, providing crucial support in guiding public health responses. Understanding the benefits and potential pitfalls of these models is essential for effective decision-making during emergencies.

LANCET DIGITAL HEALTH (2021)

Add to Collection

Article Biology

Clinically Relevant Pancreatic Fistula after Pancreaticoduodenectomy: How We Do It

Jana Enderes, Christiane Pillny, Hanno Matthaei, Steffen Manekeller, Joerg C. Kalff, Tim R. Glowka

Summary: Pancreatic cancer is a highly aggressive tumor with poor prognosis. Surgery combined with chemotherapy is the only chance for long-term survival, but it is a complex procedure with risks of complications. This study investigated the risk factors and treatment strategies for leakage of pancreatic fluid after surgery. The data showed that patients with leakage were younger, mainly male, with fewer comorbidities, higher body mass index, smaller tumor size, and softer pancreatic parenchyma. Treatment strategies included conservative treatment, drainage placement, endoscopic negative pressure therapy and surgery. Most patients received conservative treatment, resulting in shorter hospital stays.

BIOLOGY-BASEL (2023)

Add to Collection

Review Plant Sciences

The mystery remains: How do potyviruses move within and between cells?

Mingshuo Xue, Nathalie Arvy, Sylvie German-Retana

Summary: In this review, the authors compile and integrate data on the transport of potyviruses, which are the largest single-stranded RNA viruses, causing economic damage to crops. They propose three potential mechanisms for viral transport and discuss experimental evidence supporting these models.

MOLECULAR PLANT PATHOLOGY (2023)

Add to Collection

Article Pharmacology & Pharmacy

Do we really understand how drug eluted from stents modulates arterial healing?

Alistair McQueen, Javier Escuer, Ankush Aggarwal, Simon Kennedy, Christopher McCormick, Keith Oldroyd, Sean McGinty

Summary: The introduction of drug-eluting stents (DES) has transformed the treatment of coronary artery disease, with a focus on improving patient outcomes through advancements in stent technology. Mathematical and computational modelling plays a key role in studying structural mechanics, computational fluid dynamics, drug elution kinetics, and binding within the arterial wall. However, there is a lack of models depicting the action of drugs on smooth muscle cell growth after stent deployment.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)

Add to Collection

Article Nutrition & Dietetics

Exercise Is Medicine: How Do We Implement It?

Aliya Khasanova, Tara M. Henagan

Summary: Exercise has beneficial effects on various diseases, such as obesity, type 2 diabetes, cardiovascular disease, heart failure, cancer, and psychological well-being. This paper discusses the fundamental concepts shared among these disease states and highlights the potential impacts and challenges to medical professionals and patients in implementing exercise recommendations. The limitations of the current built environment in supporting physical activity recommendations are also addressed.

NUTRIENTS (2023)

Add to Collection

Article Nutrition & Dietetics

Toward a healthy and sustainable diet in Mexico: where are we and how can we move forward?

Anali Castellanos-Gutierrez, Tania G. Sanchez-Pimienta, Carolina Batis, Walter Willett, Juan A. Rivera

Summary: The study found that Mexican adults have a diet that deviates from a healthy pattern, with excessive intake of grains, dairy, sugar, and animal-based proteins, and insufficient intake of vegetables and fruits. Therefore, a healthy and sustainable reference diet tailored to the Mexican population was proposed based on these findings.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2021)

Add to Collection

Article Allergy

Real-life management of patients with severe asthma in the biologics era: Can we do better?

Jeremy Charriot, Milka Maravic, Michael Huguet, Isabelle Vachier, Carey Suehs, Arnaud Bourdin

Summary: This study investigated the treatment profile of severe asthma patients in France in 2018, revealing discrepancies between guidelines and real-life practice. The findings emphasized the need for improved patient phenotyping and provided insight into the positioning of current and forthcoming biologics.

WORLD ALLERGY ORGANIZATION JOURNAL (2021)

Add to Collection

Article Psychology, Mathematical

How do we regard fictional people? How do they regard us?

Meghan M. Salomon-Amend, Lance J. Rips

Summary: Readers expect the rules of reality to apply in realistic fiction, but there is debate over whether real individuals exist in the fictional world. The experiments show that participants are more willing to accept the existence of a real individual in the world of a fictional character than vice versa. However, this asymmetry is affected by spatial and temporal constraints, with interchange more likely when the person and character share settings.

PSYCHONOMIC BULLETIN & REVIEW (2023)

Add to Collection

Review Dentistry, Oral Surgery & Medicine

How do we and how should we deal with uncertainty in endodontics?

Maria Pigg, Josephine Broden, Helena Fransson, Niklas Vareman

Summary: This paper explores the concept of uncertainty and its different dimensions, using persistent apical periodontitis associated with a previously root filled tooth as an example. The recognition and acceptance of uncertainty in clinical situations is necessary for making sound decisions and managing its consequences.

INTERNATIONAL ENDODONTIC JOURNAL (2022)

Add to Collection

Article Meteorology & Atmospheric Sciences

How Well do We Understand the Planck Feedback?

Timothy W. Cronin, Ishir Dutta

Summary: Understanding the radiative response to warming is crucial for predicting global warming. The difference between the radiative response estimated by climate models and the theoretical estimate is mainly due to the lack of stratospheric warming in the models. Neglecting this warming can lead to an overly optimistic analysis of climate change feedbacks.

JOURNAL OF ADVANCES IN MODELING EARTH SYSTEMS (2023)

Add to Collection

Article Multidisciplinary Sciences

Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy

Yuling Xiao, Jiang Chen, Hui Zhou, Xiaodong Zeng, Zhiping Ruan, Zhangya Pu, Xingya Jiang, Aya Matsui, Lingling Zhu, Zohreh Amoozgar, Dean Shuailin Chen, Xiangfei Han, Dan G. Duda, Jinjun Shi

Summary: In this study, the authors demonstrate that combining CXCR4-targeted p53 mRNA nanoparticles with anti-PD-1 therapy effectively reverses immunosuppression and improves anti-tumor effects in hepatocellular carcinoma models.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Oncology

Predictive Modeling of Survival and Toxicity in Patients With Hepatocellular Carcinoma After Radiotherapy

Ibrahim Chamseddine, Yejin Kim, Brian De, Issam El Naqa, Dan G. Duda, John Wolfgang, Jennifer Pursley, Harald Paganetti, Jennifer Wo, Theodore Hong, Eugene J. Koay, Clemens Grassberger

Summary: This study developed machine learning models to predict treatment failure and radiation-induced toxicities in patients with hepatocellular carcinoma after radiotherapy. The models demonstrated excellent performance, particularly in high-risk patients, and could be used for patient stratification and treatment selection.

JCO CLINICAL CANCER INFORMATICS (2022)

Add to Collection

Article Oncology

Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition

John D. Martin, Ryan M. Lanning, Vikash P. Chauhan, Margaret R. Martin, Ahmed S. Mousa, Walid S. Kamoun, Hee -Sun Han, Hang Lee, Triantafyllos Stylianopoulos, Moungi G. Bawendi, Dan G. Duda, Edward B. Brown, Timothy P. Padera, Dai Fukumura, Rakesh K. Jain

Summary: This study reveals the spatial and temporal heterogeneity in tumor vessel function and oxygen levels, which can affect the response to therapeutic agents. The findings suggest that optimizing the dose and schedule of vascular and stromal normalizing strategies should take into account the dynamic changes in tumor vasculature.

CLINICAL CANCER RESEARCH (2022)

Add to Collection

Article Oncology

Increased CD8+ T-cell Infiltration and Efficacy for Multikinase Inhibitors After PD-1 Blockade in Hepatocellular Carcinoma

Hiroto Kikuchi, Aya Matsui, Satoru Morita, Zohreh Amoozgar, Koetsu Inoue, Zhiping Ruan, Daniel Staiculescu, Jeffrey Sum-Lung Wong, Peigen Huang, Thomas Yau, Rakesh K. Jain, Dan G. Duda

Summary: Immune checkpoint blockade combined with antiangiogenic therapy is effective for hepatocellular carcinoma (HCC), and initial immunotherapy can enhance the efficacy of subsequent antiangiogenic therapy.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)

Add to Collection

Article Medicine, Research & Experimental

VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway

Zhangya Pu, Dan G. Duda, Yuanyuan Zhu, Siya Pei, Xiaofang Wang, Yan Huang, Panpan Yi, Zebing Huang, Fang Peng, Xingwang Hu, Xuegong Fan

Summary: This study found that VCP is significantly increased in HCC tissues and is associated with advanced TNM stages and poorer prognosis. VCP overexpression promotes HCC cell proliferation, migration, and invasion via PI3K/AKT/mTOR pathway activation. Additionally, VCP interacts with HMGB1 and enhances its protein stability, contributing to HCC progression.

JOURNAL OF TRANSLATIONAL MEDICINE (2022)

Add to Collection

Article Oncology

A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma

Giselle Saulnier-Sholler, Dan G. Duda, Genevieve Bergendahl, David Ebb, Matija Snuderl, Theodore W. Laetsch, Jennifer Michlitsch, Derek Hanson, Michael S. Isakoff, Kevin Bielamowicz, Jacqueline M. Kraveka, William Ferguson, Peter Carmeliet, A. De Deene, Lore Gijsen, Rakesh K. Jain

Summary: TB-403 is safe and well tolerated in pediatric patients with relapsed or refractory cancers, and shows potential for stabilizing disease in medulloblastoma patients.

CLINICAL CANCER RESEARCH (2022)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Refining genetic and molecular classifications to facilitate breakthrough treatments in intrahepatic cholangiocarcinoma: are we there yet?

Satoru Morita, Dan G. Duda

GUT (2023)

Add to Collection

Editorial Material Oncology

Revisiting Antiangiogenic Multikinase Inhibitors in the Era of Immune Checkpoint Blockade: The Case of Sorafenib

Dan G. Duda, Rakesh K. Jain

Summary: The successful development of multikinase inhibitors has revolutionized the treatment of malignant cancers, and the emergence of immunotherapy has raised important questions about treatment interaction with antiangiogenic drugs. Revealing the mechanism of action between these two is crucial to improve treatment outcomes.

CANCER RESEARCH (2022)

Add to Collection

Article Gastroenterology & Hepatology

Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers

Bolni Marius Nagalo, Yumei Zhou, Emilien J. Loeuillard, Chelsae Dumbauld, Oumar Barro, Alexander T. Baker, Mansi Arora, James M. Bogenberger, Natalie Meurice, Joachim Petit, Pedro Luiz Serrano Uson, Faaiq Asiam, Elizabeth Raupach, Musa Gabere, Alexei Basnakian, Camila C. Simoes, Martin J. Cannon, Steven R. Post, Kenneth Buetow, Jean Christopher Chamcheu, Michael T. Barrett, Dan G. Duda, Bertram Jacobs, Richard Vile, Michael A. Barry, Lewis R. Roberts, Sumera Llyas, Mitesh J. Borad

Summary: This study demonstrates that wild-type Morreton virus has potential therapeutic effects on cholangiocarcinoma and hepatocellular carcinoma in vitro models. It can induce immune responses and lead to tumor regression. These findings support further development and clinical translation of Morreton virus as an oncolytic virotherapy platform.

HEPATOLOGY (2023)

Add to Collection

Article Multidisciplinary Sciences

Immune modulation by molecularly targeted photothermal ablation in a mouse model of advanced hepatocellular carcinoma and cirrhosis

Nina M. Munoz, Crystal Dupuis, Malea Williams, Katherine Dixon, Amanda McWatters, Jie Zhang, Swathi Pavuluri, Arvind Rao, Dan G. Duda, Ahmed Kaseb, Rahul A. Sheth

Summary: This study evaluated the morphologic and immunologic effects of a molecularly targeted photothermal ablation technology in an immunotherapy-resistant HCC mouse model. The results showed that this technology increased the number of activated T cells and decreased regulatory T cells in the tumor, and also had influence on systemic tumor immunity.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Gastroenterology & Hepatology

Distinct single-cell immune ecosystems distinguish true and de novo HBV-related hepatocellular carcinoma recurrences

Shuling Chen, Cheng Huang, Guanrui Liao, Huichuan Sun, Yubin Xie, Changyi Liao, Jianping Wang, Minghui He, Huanjing Hu, Zihao Dai, Xiaoxue Ren, Xuezhen Zeng, Zhilong Lin, Guo-Pei Zhang, Wenxuan Xie, Shunli Shen, Shaoqiang Li, Sui Peng, Dong-Ming Kuang, Qiang Zhao, Dan G. Duda, Ming Kuang

Summary: Analyzing the single-cell immune ecosystems in recurrent hepatocellular carcinoma (HCC) can aid in the development of effective immunotherapies. The study identified de novo and true recurrences in HCC samples and found distinct immune characteristics in the tumor immune microenvironment (TIME) of these recurrences. The findings suggest the need for different immunotherapy strategies based on the type of HCC recurrence and the specific TIME.

GUT (2023)

Add to Collection

Article Oncology

Inhibition of CXCR4 Enhances the Efficacy of Radiotherapy in Metastatic Prostate Cancer Models

Nisha Gupta, Hiroki Ochiai, Yoshinori Hoshino, Sebastian Klein, Jozef Zustin, Rakesh R. Ramjiawan, Shuji Kitahara, Nir Maimon, Despina Bazou, Sarah Chiang, Sen Li, Daniel H. Schanne, Rakesh. K. Jain, Lance L. Munn, Peigen Huang, Sergey V. Kozin, Dan G. Duda

Summary: Radiotherapy is an important treatment for advanced prostate cancer. Inhibition of the SDF1 alpha/CXCR4 axis, which mediates metastasis and resistance to radiotherapy, may be a potential therapeutic target for prostate cancer patients. Inhibition of CXCR4 with AMD3100 enhances the effect of local radiotherapy and reduces lymph node metastasis. It also promotes the normalization of vasculature and reduces tissue hypoxia in bone metastatic prostate cancer.

CANCERS (2023)

Add to Collection

Article Oncology

Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+Cancer Cells in Locally Advanced Pancreatic Cancer

Yves Boucher, Jessica M. Posada, Sonu Subudhi, Ashwin S. Kumar, Spencer R. Rosario, Liqun Gu, Heena Kumra, Mari Mino-Kenudson, Nilesh P. Talele, Dan G. Duda, Dai Fukumura, Jennifer Y. Wo, Jeffrey W. Clark, David P. Ryan, Carlos Fernandez-Del Castillo, Theodore S. Hong, Mikael J. Pittet, Rakesh K. Jain

Summary: In this study, we found that adding losartan (LOS) to FOLFIRINOX (FFX) chemotherapy followed by chemoradiation (CRT) in patients with locally advanced pancreatic cancer (LAPC) resulted in a 61% R0 surgical resection rate. By evaluating the effects of neoadjuvant LOS on the tumor microenvironment, we identified potential mechanisms of benefit. The results showed that LOS+FFX+CRT reduced the expression of immunosuppression and pro-invasion genes and was associated with improved overall survival (OS).

CLINICAL CANCER RESEARCH (2023)

Add to Collection

Article Oncology

Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer

Eleni Gkika, Elke Firat, Sonja Adebahr, Erika Graf, Ilinca Popp, Gianluca Radicioni, Simon S. Lo, Ursula Nestle, Nils H. Nicolay, Gabriele Niedermann, Dan G. Duda, Anca-L. Grosu

Summary: We conducted a prospective study to investigate the changes in circulating immune cells after stereotactic body radiotherapy (SBRT) in early-stage NSCLC patients. We found no significant increase in CD8(+) cytotoxic T lymphocytes at the first follow-up, but observed a significant expansion in Ki-67(+)CD8(+) and Ki-67(+)CD4(+) T-cell fractions in patients receiving 10 Gy or less per fraction. Our findings suggest that SBRT can induce immediate expansion of circulating effector T-cells.

NPJ PRECISION ONCOLOGY (2023)

Add to Collection

Review Oncology

The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma

Betul Gok Yavuz, Saumil Datar, Shadi Chamseddine, Yehia I. Mohamed, Michael LaPelusa, Sunyoung S. Lee, Zishuo Ian Hu, Eugene J. Koay, Hop S. Tran Cao, Prasun Kumar Jalal, Carrie Daniel-MacDougall, Manal Hassan, Dan G. Duda, Hesham M. Amin, Ahmed O. Kaseb

Summary: Hepatocellular carcinoma (HCC) is the most common type of liver cancer, and the gut microbiome may play a role in its detection and treatment, particularly in immunotherapy. This review examines the gut microbiome's potential as a biomarker for HCC and its impact on immunotherapy. It also discusses the bidirectional interactions between the gut and liver and the role of gut microbiota in cancer treatment.

CANCERS (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.